Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM)

被引:13
|
作者
Gonzalez-Cao, Maria [1 ]
Puertolas, Teresa [2 ]
Riveiro, Mar [3 ]
Munoz-Couselo, Eva [4 ]
Ortiz, Carolina [4 ]
Paredes, Roger [5 ,6 ]
Podzamczer, Daniel [7 ]
Luis Manzano, Jose [8 ]
Molto, Jose [5 ,6 ]
Revollo, Boris [5 ,6 ]
Carrera, Cristina [9 ]
Mateu, Lourdes [5 ,6 ]
Fancelli, Sara [1 ,10 ]
Espinosa, Enrique [11 ]
Clotet, Bonaventura [5 ,6 ]
Martinez-Picado, Javier [5 ,12 ]
Cerezuela, Pablo [13 ]
Soria, Ainara [14 ]
Marquez, Ivan [15 ]
Mandala, Mario [16 ]
Berrocal, Alfonso [17 ]
机构
[1] Dexeus Univ Hosp, Inst Oncol Dr Rosell, Translat Canc Res Unit, Barcelona, Spain
[2] Hosp Univ Miguel Servet, Oncol Dept, Zaragoza, Aragon, Spain
[3] Vall dHebron Hosp Univ, Dept Internal Med, Liver Unit, Barcelona, Spain
[4] Vall dHebron Hosp Univ, Oncol Dept, Barcelona, Catalunya, Spain
[5] IrsiCaixa AIDS Res Inst, Badalona, Catalunya, Spain
[6] Hosp Badalona Germans Trias & Pujol, Dept Infect Dis, Badalona, Catalunya, Spain
[7] Hosp Univ Bellvitge, Dept Infect Dis, Lhospitalet De Llobregat, Catalunya, Spain
[8] Hosp Badalona Germans Trias & Pujol, Onol Dept, Badalona, Spain
[9] Hosp Clin Barcelona, Dermatol Dept, Melanoma Grp IDIBAPS, Barcelona, Catalunya, Spain
[10] Azienda Osped Careggi, Oncol Dept, Florence, Toscana, Italy
[11] Hosp Univ La Paz, Oncol Dept, Madrid, Spain
[12] Catalan Inst Res & Adv Studies, Catalan Inst Res & Adv Studies ICREA, Barcelona, Catalunya, Spain
[13] Hosp Virgen Arrixaca, Oncol Dept, Murcia, Spain
[14] Hosp Ramon & Cajal, Oncol Dept, Madrid, Spain
[15] Hosp Gen Univ Gregorio Maranon, Oncol Dept, Madrid, Spain
[16] ASST Papa Giovanni XXIII, Oncol Dept, Bergamo, Italy
[17] Consorci Hosp Gen Univ Valencia, Oncol Dept, Valencia, Comunitat Valen, Spain
关键词
immunotherapy; IMMUNE CHECKPOINT INHIBITORS; HEPATITIS-B REACTIVATION; TUBERCULOSIS; NIVOLUMAB; THERAPY; HIV; INFECTION; REJECTION; DISEASE; SAFETY;
D O I
10.1136/jitc-2020-001664
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer immunotherapy based on the use of antibodies targeting the so-called checkpoint inhibitors, such as programmed cell death-1 receptor, its ligand, or CTLA-4, has shown durable clinical benefit and survival improvement in melanoma and other tumors. However, there are some special situations that could be a challenge for clinical management. Persons with chronic infections, such as HIV-1 or viral hepatitis, latent tuberculosis, or a history of solid organ transplantation, could be candidates for cancer immunotherapy, but their management requires a multidisciplinary approach. The Spanish Melanoma Group (GEM) panel in collaboration with experts in virology and immunology from different centers in Spain reviewed the literature and developed evidence-based guidelines for cancer immunotherapy management in patients with chronic infections and immunosuppression. These are the first clinical guidelines for cancer immunotherapy treatment in special challenging populations. Cancer immunotherapy in chronically infected or immunosuppressed patients is feasible but needs a multidisciplinary approach in order to decrease the risk of complications related to the coexistent comorbidities.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Cancer immunotherapy in special challenging populations: recommendations of the advisory Committee of Spanish Melanoma Group (GEM) (vol 9, e001664, 2021)
    Gonzalez-Cao, M.
    Puertolas, T.
    Riveiro, M.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (02)
  • [2] Predictive factors of response to immunotherapy-a review from the Spanish Melanoma Group (GEM)
    Espinosa, Enrique
    Marquez-Rodas, Ivan
    Soria, Ainara
    Berrocal, Alfonso
    Luis Manzano, Jose
    Gonzalez-Cao, Maria
    Martin-Algarra, Salvador
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (19)
  • [3] Report from the II Melanoma Translational Meeting of the Spanish Melanoma Group (GEM)
    Gonzalez-Cao, Maria
    Berrocal, Alfonso
    Puig, Susana
    Karachaliou, Niki
    De Matos-Arruda, Leticia
    Seoane, Joan
    Escors, David
    Alvarez, Carmen
    Pedro Vaque, Jose
    Prat, Aleix
    Wellbrock, Claudia
    Arozarena, Imanol
    Marquez-Rodas, Ivan
    Espinosa, Enrique
    Angel Molina, Migue
    Puertolas, Teresa
    Juan-Otero, Manuel
    Malagrida, Rosina
    Jantus-Lewintre, Eloisa
    Soriano, Virtudes
    Arance, Ana
    Luis Manzano, Jose
    Lorigan, Paul
    Gajewski, Thomas F.
    Rosell, Rafael
    Martin-Algarra, Salvador
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (19)
  • [4] Spanish Multidisciplinary Melanoma Group (GEM) guidelines for the management of patients with advanced melanoma
    Alfonso Berrocal
    Enrique Espinosa
    Severiano Marín
    Josep Malvehy
    David Moreno
    Maria Dolores Lozano
    Salvador Martin-Algarra
    Jose Antonio Lopez
    Carlos Conill
    Jose Luis Rodriguez-Peralto
    European Journal of Dermatology, 2015, 25 : 392 - 403
  • [5] Spanish Multidisciplinary Melanoma Group (GEM) guidelines for the management of patients with advanced melanoma
    Berrocal, Alfonso
    Espinosa, Enrique
    Marin, Severiano
    Malvehy, Josep
    Moreno, David
    Dolores Lozano, Maria
    Martin-Algarra, Salvador
    Antonio Lopez, Jose
    Conill, Carlos
    Luis Rodriguez-Peralto, Jose
    EUROPEAN JOURNAL OF DERMATOLOGY, 2015, 25 (05) : 392 - 403
  • [6] Recent developments in the recommendations of the Vaccine Advisory Committee of the Spanish Association of Pediatrics for the year 2016
    Alvarez Garcia, F.
    BOLETIN DE PEDIATRIA, 2016, 56 (235): : 38 - 44
  • [7] Highlights of the season 2016-2017 by the Spanish Melanoma Group (GEM)
    Soria, Ainara
    Luis Manzano, Jose
    Berrocal, Alfonso
    Espinosa, Enrique
    Marquez-Rodas, Ivan
    Gonzalez-Cao, Maria
    Martin-Algarra, Salvador
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (19)
  • [8] Immunotherapy Management in Special Cancer Patient Populations
    Ramnaraign, Brian H.
    Chatzkel, Jonathan A.
    Al-Mansour, Zeina A.
    Rogers, Sherise
    Jones, Dennie
    DeRemer, David
    George, Thomas J.
    JCO ONCOLOGY PRACTICE, 2021, 17 (05) : 240 - +
  • [9] Oncologic Drugs Advisory Committee Recommendations and Approval of Cancer Drugs by the US Food and Drug Administration
    Tibau, Ariadna
    Ocana, Alberto
    Anguera, Georgia
    Seruga, Bostjan
    Templeton, Arnoud J.
    Barnadas, Agusti
    Amir, Eitan
    JAMA ONCOLOGY, 2016, 2 (06) : 744 - 750
  • [10] SPANISH MELANOMA MULTIDISCIPLINARY GROUP (GEM) EXPERIENCE WITH IPILIMUMAB (IPI) IN THE EXPANDED ACCESS PROGRAMME (EAP)
    Martin Algarra, S.
    Alonso, L.
    Valdivia, J.
    Garcia Castano, A.
    Escrig, V.
    Mut, P.
    Ballesteros, A.
    Puertolas, T.
    Ortega, E.
    Berrocal, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 374 - 374